Covered recipient · General Payments record
TAMMY L COOPER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2022–2023
$619.33
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $572.10 | 17 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $235.35 | 3 |
| ITI, Inc. | $164.05 | 4 |
| Novo Nordisk AS | $64.64 | 4 |
| ABBVIE INC. | $39.58 | 2 |
| ViiV Healthcare Company | $34.51 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.01 | 1 |
| Corium, Inc. | $14.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.27 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003484061 | CMS |
| ABBVIE INC. | $20.31 | 04/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003484065 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.85 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015825089 | CMS |
| AstraZeneca Pharmaceuticals LP | $95.40 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015682599 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.10 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015905949 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.01 | 03/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997057729 | CMS |
| Corium, LLC | $14.96 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978049705 | CMS |
| ITI, Inc. | $25.17 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040848463 | CMS |
| ITI, Inc. | $25.65 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040848473 | CMS |
| ITI, Inc. | $83.92 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040848477 | CMS |
| ITI, Inc. | $29.31 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040848485 | CMS |
| Novo Nordisk Inc | $15.18 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002680463 | CMS |
| Novo Nordisk Inc | $13.24 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002680447 | CMS |
| Novo Nordisk Inc | $19.26 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002680491 | CMS |
| Novo Nordisk Inc | $16.96 | 05/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002680479 | CMS |
| ViiV Healthcare Company | $14.70 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001318673 | CMS |
| ViiV Healthcare Company | $19.81 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001319391 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.